Clinical Data,,,,,,,,,,,,,,,,,,,,,,,,,,10X Run Data,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pre-Filter,,,,Post-Filter,,
Patient ID,Health Status,Gender,Age range at Surgery,Menopause Status,Histopathology,T Staging,N Staging,M Staging,Grade,Grade comment,Lymph Node Status (L),Resection,ER Status by IHC,ER IRS Score,ER percent positive cells by IHC,PR Status by IHC,PR IRS Score,PR percent positive cells by IHC,HER2 Status by IHC,HER2 IHC Score,HER2 Status by FISH or SISH,Ki-67 percent positive cells by IHC,Clinical Subtype,Neoadjuvant Therapy Received,Previous Cancer Incidences,10x Chromium Run,Date,10x Chromium Chemistry,Cells sequenced,Median genes per cell,Mean reads per cell,Sequencing Saturation [%],Cells sequenced,Median genes per cell,Mean reads per cell
BB011,Breast cancer patient,F,71-80,post,InvasiveDuctalCarcinoma,pT3,N1a,M1pul,G3,na,L1,R0,P,12,na,P,6,na,N,0,na,70,LumB,no,na,7,20191008,"v3, 3' Reagent Kits",12584,1523,34733,50.8,10312,1536,7703
BB035,Breast cancer patient,F,41-50,pre,InvasiveLobularCarcinoma-mixed-TubularCarcinoma,pT2,N0,M0,G1,na,L0,R0,P,12,na,P,12,na,N,1,na,20,LumB,no,na,6,20191008,"v3, 3' Reagent Kits",11577,2156,83106,70.8,8857,2230,11942
BB075,Breast cancer patient,F,61-70,post,InvasiveDuctalCarcinoma,pT2,N0,M0,G3,na,L0,R0,P,12,na,P,12,na,N,1,na,20,LumB,no,na,5,20190515,"v3, 3' Reagent Kits",9904,3011,58706,28.7,6985,3373,17486
BB102,Breast cancer patient,F,61-70,post,InvasiveLobularCarcinoma,pT2,N1a,M0,G2,na,L0,R0,P,12,na,P,6,na,N,1,na,15,LumA,no,na,3,20190514,"v3, 3' Reagent Kits",6980,2714,73268,54.3,4050,2948,15461
BB111,Breast cancer patient,F,41-50,pre,InvasiveMucinousCarcinoma,pT2,N1,M0,G1,na,na,Rx,P,12,na,P,12,na,N,0,na,5,LumA,no,na,3,20190514,"v3, 3' Reagent Kits",8114,2832,66386,54.9,6278,3012,15420
BB129,Breast cancer patient,F,81-90,post,InvasiveDuctalCarcinoma,pT2,N0,M0,G3,na,na,R0,P,12,na,P,3,na,N,1,na,20,LumB,no,na,2,20190513,"v3, 3' Reagent Kits",18993,1955,28213,35.7,14451,1963,8091
BB165,Breast cancer patient,F,31-40,pre,InvasiveDuctalCarcinoma,ypT2,N0,M0,G3,preneoadjuvant assessment,na,R0,N,0,na,N,0,na,N,1,na,80,TN,yes,na,5,20190515,"v3, 3' Reagent Kits",7825,2448,61339,41.6,5309,2647,13274
BB171,Breast cancer patient,F,31-40,pre,InvasiveDuctalCarcinoma,ypT2,N0,M0,G3,preneoadjuvant assessment,na,R0,N,1,na,P,3,na,N,0,na,60,LumB,yes,na,4,20190514,"v3, 3' Reagent Kits",10000,2790,51403,37.3,8078,2928,16255
BB184,Breast cancer patient,F,51-60,post,InvasiveDuctalCarcinoma,pT2,N0,M0,G2,na,L0,R0,N,1,na,P,6,na,N,0,na,35,LumB,no,yes,6,20191008,"v3, 3' Reagent Kits",14548,1331,19117,29.4,8144,1397,5879
BB212,Breast cancer patient,F,41-50,pre,InvasiveDuctalCarcinoma,pT1c,N1a,M0,G3,na,L1,R0,P,12,na,P,12,na,N,1,na,40,LumB,no,na,7,20191008,"v3, 3' Reagent Kits",9338,1854,49108,53.6,6737,1677,8924
BB214,Breast cancer patient,F,71-80,post,InvasiveDuctalCarcinoma,pT2,N0,M0,G2,na,L0,R0,P,12,na,P,6,na,N,2,negative,30,LumB,no,yes,2,20190513,"v3, 3' Reagent Kits",11809,2229,49053,54.5,10036,2189,9659
BB226,Breast cancer patient,F,41-50,pre,InvasiveDuctalCarcinoma,pT2(m),N1a,M0,G1,na,Lx,R0,P,12,na,P,12,na,N,0,na,5,LumA,no,na,4,20190514,"v3, 3' Reagent Kits",10140,2735,49245,48,7851,2811,12579
BB330,Breast cancer patient,F,91-100,post,InvasiveDuctalCarcinoma,pT1c(m),Nx,Mx,G3,na,na,R0,P,12,na,P,8,na,P,2,positive,na,LumB/HER2,no,na,1,20190122,"v3, 3' Reagent Kits",10329,1587,48269,61.5,7796,1776,9295
BB338,Breast cancer patient,F,51-60,pre,InvasiveDuctalCarcinoma-mixed with other types,pT1c,N0,Mx,G3,na,na,R0,N,0,na,P,3,na,N,0,na,85,LumB,no,yes,1,20190122,"v3, 3' Reagent Kits",17357,1979,22822,27.5,13923,2012,8604